Omega 3 fatty acid treatment in autism

Area of Science:

• Neuroscience
• Pediatric Medicine
• Nutritional Science

Background:

• Autistic spectrum disorder (ASD) is a complex neurodevelopmental condition.
• Current treatments for ASD focus on managing symptoms and improving quality of life.
• Investigating novel therapeutic interventions, such as nutritional supplements, is crucial.

Purpose of the Study:

• To evaluate the efficacy and safety of omega-3 fatty acid supplementation in children diagnosed with ASD.
• To determine if omega-3 fatty acids can lead to measurable improvements in ASD-related behaviors and symptoms.

Main Methods:

• An open-label pilot study was conducted with 10 children aged 4-7 years diagnosed with ASD (DSM-IV criteria).
• Participants received a daily dosage of 1 gram of omega-3 fatty acids for a duration of 12 weeks.
• The Autism Treatment Evaluation Checklist (ATEC) was utilized as the primary outcome measure to assess changes in ASD symptoms.

Main Results:

• Eight out of nine children who completed the study demonstrated an approximate 33% improvement on the ATEC scores.
• No participants experienced a worsening of their condition.
• No adverse side effects were reported during the supplementation period.

Conclusions:

• Omega-3 fatty acids appear to be a safe intervention for children with ASD.
• Preliminary findings suggest that omega-3 fatty acids may offer therapeutic benefits for children with autistic spectrum disorder.
• Further research, including larger double-blind, placebo-controlled trials with varied dosages, is warranted to confirm these findings.